DEA Archived Press Releases

Press Releases before January 20, 2025
787 Results - Showing 281 to 290
PRESS RELEASE

Former leader of Kenyan organized crime family and his brother plead guilty to narcotics, weapons, and obstruction offenses

NEW YORK - Raymond P. Donovan, the Special Agent in Charge of the DEA Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York announced that Baktash Akasha Abdalla, aka “Baktash Akasha,” and Ibrahim Akasha Abdalla, aka “Ibrahim Akasha,” pled guilty yesterday...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

WASHINGTON – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall 2018...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

NEW ORLEANS – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the U.S. Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming...
PRESS RELEASE

New Orleans-area defendants plead guilty to fraudulent possession and black market distribution of oxycodone

NEW ORLEANS – Eight New Orleans-area defendants have pleaded guilty for their participation in a conspiracy to obtain oxycodone through fraud by using fictitious prescriptions. Six of the eight defendants have also pleaded guilty for their roles in a scheme to possess with intent to distribute oxycodone on the black...
PRESS RELEASE

DEA to kick off annual Red Ribbon Campaign

WASHINGTON – The United States Drug Enforcement Administration is gearing up to kick off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, which launches October 23. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in...
PRESS RELEASE

Justice, Treasury, and State Departments announce coordinated enforcement efforts against Cartel Jalisco Nueva Generacion

WASHINGTON – The United States of America, through its Departments of Justice, Treasury, and State announced today a series of measures to target and dismantle the Cartel Jalisco Nueva Generacion (CJNG) – one of the largest, most dangerous drug cartels currently operating in Mexico. These measures include the unsealing of...
PRESS RELEASE

DEA Acting Administrator underscores the importance of drug enforcement efforts to combat opioid epidemic

SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...
PRESS RELEASE

DEA and law enforcement partners announce significant progress in making communities safer through Project Safe Neighborhoods and Project Eject

JACKSON, Miss. – In October 2017, the Department of Justice announced the revitalization and enhancement of Project Safe Neighborhoods, which Attorney General Jeff Sessions has made the centerpiece of the Department’s violent crime reduction strategy. PSN is an evidence-based program proven to be effective at reducing violent crime. Through PSN...
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...